Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-05 Sale | 2025-12-05 6:53 pm | ENANTA PHARMACEUTICALS INC | ENTA | Capps Kathleen S. See Remarks | 323 | $14.23 | $4,596 | 8,377 (Direct) | View |
| 2025-12-05 Sale | 2025-12-05 6:47 pm | ENANTA PHARMACEUTICALS INC | ENTA | Trout Harry R. III See Remarks | 542 | $14.23 | $7,713 | 16,348 (Direct) | View |
| 2025-12-05 Sale | 2025-12-05 6:46 pm | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer | 798 | $14.23 | $11,356 | 21,792 (Direct) | View |
| 2025-12-05 Sale | 2025-12-05 6:45 pm | ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Chief Business Officer | 1,394 | $14.23 | $19,837 | 38,329 (Direct) | View |
| 2025-12-05 Sale | 2025-12-05 6:44 pm | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 2,106 | $14.23 | $29,968 | 30,620 (Direct) | View |
| 2025-12-05 Sale | 2025-12-05 6:43 pm | ENANTA PHARMACEUTICALS INC | ENTA | Or Yat Sun Chief Scientific Officer | 2,390 | $14.23 | $34,010 | 371,392 (Direct) | View |
| 2025-12-05 Sale | 2025-12-05 6:41 pm | ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO | 4,743 | $14.23 | $67,493 | 858,026 (Direct) | View |
| 2025-12-02 Sale | 2025-12-03 5:09 pm | ENANTA PHARMACEUTICALS INC | ENTA | Capps Kathleen S. See Remarks | 207 | $13.96 | $2,890 | 8,700 (Direct) | View |
| 2025-12-02 Sale | 2025-12-03 5:05 pm | ENANTA PHARMACEUTICALS INC | ENTA | Trout Harry R. III See Remarks | 380 | $13.96 | $5,305 | 16,890 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-11 Option Award | 2026-03-13 4:20 pm | N/A 2036-03-11 | ENANTA PHARMACEUTICALS INC | ENTA | Vance Terry Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2026-03-11 Option Award | 2026-03-13 4:19 pm | N/A 2036-03-11 | ENANTA PHARMACEUTICALS INC | ENTA | Russell Lesley Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2026-03-11 Option Award | 2026-03-13 4:18 pm | N/A 2036-03-11 | ENANTA PHARMACEUTICALS INC | ENTA | Peterson Kristine Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2026-03-11 Option Award | 2026-03-13 4:17 pm | N/A 2036-03-11 | ENANTA PHARMACEUTICALS INC | ENTA | Hata Yujiro S Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2026-03-11 Option Award | 2026-03-13 4:15 pm | N/A 2036-03-11 | ENANTA PHARMACEUTICALS INC | ENTA | FOLETTA MARK G Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2026-03-11 Option Award | 2026-03-13 4:14 pm | N/A 2036-03-11 | ENANTA PHARMACEUTICALS INC | ENTA | CARTER BRUCE L A Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2026-02-12 Tax Withholding | 2026-02-13 4:33 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kowalsky Matthew Paul Chief Legal Officer | 1,902 | $14.25 | 3,591 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-13 4:33 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kowalsky Matthew Paul Chief Legal Officer | 5,493 | $0 | 3,591 (Direct) | View |
| 2026-02-12 Tax Withholding | 2026-02-13 4:31 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Chief Business Officer | 3,257 | $14.25 | 41,634 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-13 4:31 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Chief Business Officer | 6,562 | $0 | 41,634 (Direct) | View |
| 2026-02-12 Tax Withholding | 2026-02-13 4:29 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 3,257 | $14.25 | 33,925 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-13 4:29 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 6,562 | $0 | 33,925 (Direct) | View |
| 2026-02-12 Tax Withholding | 2026-02-13 4:28 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer | 3,413 | $14.25 | 25,254 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-13 4:28 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer | 6,875 | $0 | 25,254 (Direct) | View |
| 2026-02-12 Tax Withholding | 2026-02-13 4:27 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Or Yat Sun Chief Scientific Officer | 3,413 | $14.25 | 374,854 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-13 4:27 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Or Yat Sun Chief Scientific Officer | 6,875 | $0 | 374,854 (Direct) | View |
| 2026-02-12 Tax Withholding | 2026-02-13 4:25 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO | 6,155 | $14.25 | 871,871 (Direct) | View |
| 2026-02-12 Option Award | 2026-02-13 4:25 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO | 20,000 | $0 | 871,871 (Direct) | View |
| 2025-12-01 Tax Withholding | 2025-12-03 5:09 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Capps Kathleen S. See Remarks | 85 | $14.12 | 8,700 (Direct) | View |
| 2025-12-01 Tax Withholding | 2025-12-03 5:05 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Trout Harry R. III See Remarks | 105 | $14.12 | 16,890 (Direct) | View |
| 2025-12-01 Tax Withholding | 2025-12-03 5:02 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Chief Business Officer | 498 | $14.12 | 39,723 (Direct) | View |
| 2025-12-01 Tax Withholding | 2025-12-03 4:37 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 753 | $14.12 | 32,726 (Direct) | View |
| 2025-12-01 Tax Withholding | 2025-12-03 4:36 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Or Yat Sun Chief Scientific Officer | 753 | $14.12 | 373,782 (Direct) | View |
| 2025-12-01 Tax Withholding | 2025-12-03 4:34 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO | 1,885 | $14.12 | 862,769 (Direct) | View |
| 2025-11-25 Option Award | 2025-11-26 5:24 pm | N/A 2035-11-25 | ENANTA PHARMACEUTICALS INC | ENTA | Capps Kathleen S. See Remarks | 9,488 | $0 | 15,317 (Direct) | View |
| 2025-11-25 Option Award | 2025-11-26 5:20 pm | N/A 2035-11-25 | ENANTA PHARMACEUTICALS INC | ENTA | Trout Harry R. III See Remarks | 19,388 | $0 | 30,300 (Direct) | View |
| 2025-11-25 Option Award | 2025-11-26 5:14 pm | N/A 2035-11-25 | ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Chief Business Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2025-11-25 Option Award | 2025-11-26 5:11 pm | N/A 2035-11-25 | ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Chief Product Strategy Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2025-11-25 Option Award | 2025-11-26 5:08 pm | N/A 2035-11-25 | ENANTA PHARMACEUTICALS INC | ENTA | Kowalsky Matthew Paul Chief Legal Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2025-11-25 Option Award | 2025-11-26 5:05 pm | N/A 2035-11-25 | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2025-11-25 Option Award | 2025-11-26 5:03 pm | N/A 2035-11-25 | ENANTA PHARMACEUTICALS INC | ENTA | Or Yat Sun Chief Scientific Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2025-11-25 Option Award | 2025-11-26 5:01 pm | N/A 2035-11-25 | ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO | 310,000 | $0 | 310,000 (Direct) | View |
Ownership | 2025-09-08 6:01 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Capps Kathleen S. See Remarks | 0 | $0 | 54,630 (Direct) | View |
Ownership | 2025-09-08 6:00 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Trout Harry R. III Vice President, Finance | 0 | $0 | 63,878 (Direct) | View |
| 2025-08-08 Tax Withholding | 2025-08-08 4:35 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer | 2,217 | $6.99 | 22,590 (Direct) | View |
| 2025-03-13 Option Award | 2025-03-14 5:44 pm | N/A 2035-03-13 | ENANTA PHARMACEUTICALS INC | ENTA | Vance Terry Director | 15,700 | $0 | 15,700 (Direct) | View |
| 2025-03-13 Option Award | 2025-03-14 5:43 pm | N/A 2035-03-13 | ENANTA PHARMACEUTICALS INC | ENTA | Russell Lesley Director | 15,700 | $0 | 15,700 (Direct) | View |
| 2025-03-13 Option Award | 2025-03-14 5:43 pm | N/A 2035-03-13 | ENANTA PHARMACEUTICALS INC | ENTA | Peterson Kristine Director | 15,700 | $0 | 15,700 (Direct) | View |
| 2025-03-13 Option Award | 2025-03-14 5:35 pm | N/A 2035-03-13 | ENANTA PHARMACEUTICALS INC | ENTA | Hata Yujiro S Director | 15,700 | $0 | 15,700 (Direct) | View |